Clinical Trial Update: IL-8+ naïve T Cells as a Biomarker for Thymoma Identification

View source ↗

Summary

A completed clinical trial investigates IL-8+ naïve T cells as a biomarker for identifying thymoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymoma

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Thymoma | Status: COMPLETED